FOS and cardiac hypertrophy: Histone H3 lysine K27 acetylation on the DNA promoter promotes FOS transcription, cardiomyocyte fibrosis and inflammation through the FOS/AP-1 pathway, however, SIRT3 participates in histone H3DE deacetylation, which can inhibit the occurrence of cardiac hypertrophy [83, 84].